ROBERT RIPLEY to Adenocarcinoma
This is a "connection" page, showing publications ROBERT RIPLEY has written about Adenocarcinoma.
Connection Strength
0.406
-
Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Trials. 2010 May 25; 11:62.
Score: 0.193
-
Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients. J Surg Res. 2022 11; 279:256-264.
Score: 0.112
-
Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Jan; 113(1):279-285.
Score: 0.101